Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 23, 2022
Shenandoah Biotechnology is a privately held company located in Warminster, Pennsylvania, that manufactures recombinant proteins including cytokines and growth factors. Shenandoah Biotechnology recently launched their CTG Grade™ line of cytokines and...
read more
FUJIFILM announced plans to invest approximately JPY 10 billion (approximately $90 million U.S. dollars) in order to expand its Bio CDMO Business.
read more
Wednesday, November 11, 2020
Centogene and Fujirebio Europe have entered a partnership to leverage LUMIPULSE G technology for large-scale COVID-19 antigen testing with further deployment in German airports.
read more
Vetter announced the commissioning of a new warehouse designed to help meet increasing customer market supply demands. With a total investment of approx.
read more
Wednesday, September 20, 2023
Future Fields, a biotechnology company that has built the world’s first synthetic biology system to use fruit flies for recombinant protein production, announced the launch of its contract development and manufacturing organization (CDMO) service.
read more
Monday, December 23, 2019
G-CON Manufacturing announced the expansion of its manufacturing facility for POD superstructures in College Station, TX.
read more
G-CON Manufacturing announced the company will support Just – Evotec Biologics, a wholly-owned Seattle-based company of Evotec SE, with their construction of a late-stage clinical and commercial manufacturing facility for biologics in Redmond, ...
read more
Gallus BioPharmaceuticals, LLC (Gallus), a premier
pure-play biologics contract manufacturing organization (CMO) has signed a manufacturing
agreement with Symphogen, A/S (Symphogen), a private biopharmaceutical company developing
recombinant ...
read more
Gamida Cell and Lonza announced that the companies have entered into a strategic manufacturing agreement.
read more
Gamma Biosciences, a global life sciences company serving the advanced therapy market, announced the appointment of Terry Pizzie as Chief Executive Officer (CEO) of operating company Astrea Bioseparations. Pizzie succeeds Dr. Steve Burton, who will ...
read more
Wednesday, October 06, 2021
The Gates Biomanufacturing Facility (GBF) announced a continued strategic agreement with Nkarta, Inc. to manufacture clinical supply of therapeutic Natural Killer (NK) cells. As part of this collaboration, GBF will continue to manufacture NKX101, ...
read more
Friday, September 13, 2019
GE Healthcare and Germfree are joining expertise to develop a fully integrated, expandable manufacturing solution for emerging biotherapeutics, including gene therapy.
read more
Tuesday, January 07, 2014
GE (NYSE:GE) and Thermo Fisher Scientific (NYSE:TMO) announced today that they have entered into an agreement for GE Healthcare to acquire Thermo Fisher’s HyClone™ cell culture media and sera, and gene modulation and magnetic beads businesses for ...
read more
Ajinomoto Bio-Pharma Services announced GeneDesign has joined the global organization.
read more
Wednesday, September 22, 2021
GeneQuine Biotherapeutics GmbH, a biotech company focused on the development of gene therapy for musculoskeletal disorders, announced that it has contracted Exothera S.A., a full-service Contract Development and Manufacturing Organization (CDMO), to ...
read more